TYLER TANZYUS: Open Payments
NPI 1245856657 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$815 in 44 payments from 20 companies in 2025. Trend: 2023 $207 · 2024 $1,981 · 2025 $815
Food & beverage: $815
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $292 |
| Lilly USA, LLC | 3 | $62 |
| ACADIA Pharmaceuticals Inc | 3 | $47 |
| Lundbeck LLC | 2 | $45 |
| SK Life Science, Inc. | 2 | $44 |
| Grifols USA, LLC | 2 | $35 |
| Ipsen Biopharmaceuticals, Inc | 2 | $34 |
| CSL Behring | 1 | $31 |
| Globus Medical, Inc. | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
Products named: BOTOX, UBRELVY, NUPLAZID, EMGALITY, VYEPTI, VYALEV, QULIPTA, Gamunex-C.
Industry payments across MO — which companies pay providers there.
